Bunkyo, Japan

Hiroshi Eto

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Electric Industries, Limited. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Eto. Retrieved from https://idiyas.com/inventor/hiroshi-eto-jao5e04v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Eto: Innovator in Immunology

Introduction

Hiroshi Eto is a notable inventor based in Bunkyo, Japan. He has made significant contributions to the field of immunology, particularly through his work on monoclonal antibodies. His innovative approach has led to advancements that are beneficial for various immunoassays.

Latest Patents

Hiroshi Eto holds a patent for an "Antibody reactive to hamster immunoglobulins and assay using same." This patent describes a monoclonal antibody that is specifically reactive to hamster immunoglobulins. The invention includes a hybridoma that produces this monoclonal antibody and an immunoassay that utilizes it. The monoclonal antibody serves as a secondary antibody in assays involving hamster-derived primary antibodies or antisera raised against various antigens. He has 1 patent to his name.

Career Highlights

Hiroshi Eto is associated with Sumitomo Electric Industries, Limited, where he has been able to apply his expertise in immunology. His work has contributed to the development of innovative solutions in the field, enhancing the capabilities of immunoassays.

Collaborations

Hiroshi has collaborated with notable colleagues such as Yukihito Hasunuma and Ko Okumura. Their combined efforts have fostered a productive environment for research and development in immunology.

Conclusion

Hiroshi Eto's contributions to immunology through his patent and work at Sumitomo Electric Industries, Limited highlight his role as an innovator in the field. His advancements in monoclonal antibodies are paving the way for improved immunoassays and further research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…